Amdocs director Veronique Morali buys $5,535 in company shares

Amdocs director Veronique Morali recently acquired 134 ordinary shares of the company on November 10, 2026, at a cost of $5,535. The stock price at the time of purchase was $44.79, marking a 42% decline year-to-date. Despite this downturn, a Pro analysis indicates the company to be undervalued. This purchase followed a previous acquisition on November 9, 2026, where Morali received 6,058 ordinary shares without any cost.

In total, Morali now owns 10,597 Amdocs ordinary shares. These transactions align with the broader trend of insider confidence, as Amdocs has been actively buying back shares. The company's fiscal 2026 revenue stood at $4.7 billion, reflecting a 3.6% increase, with non-GAAP earnings per share at $7.41, indicating a 6% rise. However, Amdocs' outlook for fiscal 2027 has raised concerns as the company anticipates a significant drop in revenue and profit due to a dispute with major customer T-Mobile.

This has led to a downgrade of Amdocs' stock rating from Outperform to Perform by Oppenheimer, citing weak guidance for fiscal 2027. Despite meeting Wall Street projections in its last earnings call, the company's future guidance has piqued investor interest amidst these recent developments.